NMS·Healthcare·$560M·#197 / 520 in Healthcare
TLRY Tilray Brands, Inc.
53SPECULATIVE
CATEGORY BREAKDOWN
GROWTH18
QUALITY34
STABILITY93
VALUATION100
GOVERNANCE17
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+11.5%
18
> 50% strong
Gross Margin
Revenue retained after direct costs
28.4%
38
> 50% strong
Cash Runway
Months of cash at current burn rate
39 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
24.7%
80
< 25% strong
Price / Sales
Market cap relative to trailing revenue
0.6x
100
< 3x strong
Rule of 40
Growth rate plus operating margin
5
28
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
0.8%
6
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+10.1%
40
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE TLRY WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when TLRY's score changes by 5+ points.
DATA INFO
Last updated: Aug 1, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.